The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I clinical trial of a genetically modified and oncolytic vaccinia virus GL-ONC1 with green fluorescent protein imaging (NCT009794131).
Khurum Hayat Khan
No relevant relationships to disclose
Anna-Mary Young
No relevant relationships to disclose
Joaquin Mateo
No relevant relationships to disclose
Nina Tunariu
No relevant relationships to disclose
Timothy Anthony Yap
No relevant relationships to disclose
David Shao Peng Tan
No relevant relationships to disclose
David Mansfield
No relevant relationships to disclose
Mabel Wong
No relevant relationships to disclose
Ruth Riisnaes
No relevant relationships to disclose
Kevin J. Harrington
No relevant relationships to disclose
Johann Sebastian De Bono
No relevant relationships to disclose